Evol Science Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Evol Science General Information


Owner and operator of a biotechnology company intended to identify and therapeutically exploit mechanisms of cancer cell resistance. The company's proteomics platform, metadata analysis and predictive analytics develops new targeted therapies to treat various diseases such as pancreatic cancer, acquired resistance metastatic melanoma and others, enabling doctors to make the deadly cancers survivable.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Application Software
Drug Discovery
Primary Office
  • 3711 Market Street
  • Suite 800
  • Philadelphia, PA 19104
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Evol Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view Evol Science’s complete valuation and funding history, request access »

Evol Science Patents

Evol Science Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200046749-A9 Combinations to treat cancer Granted 07-Aug-2017 00000000000
EP-3664851-A1 Combinations to treat cancer Pending 07-Aug-2017 00000000000
US-10869879-B2 Combinations to treat cancer Active 07-Aug-2017 00000000000 0
EP-3664851-A4 Combinations to treat cancer Pending 07-Aug-2017 00000000000 0
CA-3072181-A1 Combinations to treat cancer Pending 07-Aug-2017 A61K31/7068
To view Evol Science’s complete patent history, request access »

Evol Science Executive Team (4)

Name Title Board Seat Contact Info
Joseph Driscoll Co-Founder & Chief Executive Officer
Vikram Bhattacharjee Co-Founder & Primary Scientist
Tim Yen Ph.D Interim CSO
You’re viewing 3 of 4 executive team members. Get the full list »

Evol Science Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Science Center Accelerator/Incubator 000 0000 000000 0
To view Evol Science’s complete investors history, request access »